Psoriatic Arthritis Treatment Market Size, Share & Trends Report

Psoriatic Arthritis Treatment Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, DMARDs, Biologics), By Product (Prescriptions, OTC), By Type, By Route of Administration, And Segment Forecasts, 2019 - 2026

Report ID: GVR-2-68038-990-6
Number of Pages: 103
Format: Electronic (PDF)

Historical Range: 2014 - 2017
Industry:Healthcare

Market segmentation

银屑病关节炎治疗药物类前景(Revenue, USD Million, 2014 - 2026)
- NSAIDs
- DMARDs
- 生物制剂
- Others
Psoriatic Arthritis Treatment Product Type Outlook (Revenue, USD Million, 2014 - 2026)
- Prescription
- OTC
Psoriatic Arthritis Treatment Route of Administration Outlook (Revenue, USD Million, 2014 - 2026)
- Topical
- Oral
- Injectable
Psoriatic Arthritis Treatment Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
  - North America Psoriatic Arthritis Treatment Market, by Drug Class
    - NSAIDs
    - DMARDs
    - 生物制剂
    - Others
  - North America Psoriatic Arthritis Treatment Market, by Product Type
    - Prescription
    - OTC
  - North America Psoriatic Arthritis Treatment Market, by Route of Administration
    - Topical
    - Oral
    - Injectable
  - The U.S.
    - U.S. Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - U.S. Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - U.S. Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Canada
    - Canada Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Canada Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Canada Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
- Europe
  - Europe Psoriatic Arthritis Treatment Market, by Drug Class
    - NSAIDs
    - DMARDs
    - 生物制剂
    - Others
  - Europe Psoriatic Arthritis Treatment Market, by Product Type
    - Prescription
    - OTC
  - Europe Psoriatic Arthritis Treatment Market, by Route of Administration
    - Topical
    - Oral
    - Injectable
  - U.K.
    - U.K. Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - U.K. Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - U.K. Route of Administration Outlook (Revenue, USD Million, 2014 - 2026)
      - Topical
      - Oral
      - Injectable
  - Germany
    - Germany Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Germany Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Germany Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Spain
    - Spain Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Spain Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Spain Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - France
    - France Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - France Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - France Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Italy
    - Italy Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Italy Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Italy Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
- Asia Pacific
  - 亚太银屑病关节炎治疗市场,by Drug Class
    - NSAIDs
    - DMARDs
    - 生物制剂
    - Others
  - 亚太银屑病关节炎治疗市场,by Product Type
    - Prescription
    - OTC
  - 亚太银屑病关节炎治疗市场,by Route of Administration
    - Topical
    - Oral
    - Injectable
  - Japan
    - Japan Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Japan Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Japan Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - 中国
    - 中国Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - 中国Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - 中国Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - India
    - India Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - India Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - India Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - South Korea
    - South Korea Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - South Korea Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - South Korea Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Australia
    - Australia Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Australia Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Australia Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
- Latin America
  - Latin America Psoriatic Arthritis Treatment Market, by Drug Class
    - NSAIDs
    - DMARDs
    - 生物制剂
    - Others
  - Latin America Psoriatic Arthritis Treatment Market, by Product Type
    - Prescription
    - OTC
  - Latin America Psoriatic Arthritis Treatment Market, by Route of Administration
    - Topical
    - Oral
    - Injectable
  - Brazil
    - Brazil Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Brazil Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Brazil Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Mexico
    - Mexico Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Mexico Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Mexico Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Argentina
    - Argentina Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Argentina Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Argentina Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
- MEA
  - MEA Psoriatic Arthritis Treatment Market, by Drug Class
    - NSAIDs
    - DMARDs
    - 生物制剂
    - Others
  - MEA Psoriatic Arthritis Treatment Market, by Product Type
    - Prescription
    - OTC
  - MEA Route of Administration Outlook (Revenue, USD Million, 2014 - 2026)
    - Topical
    - Oral
    - Injectable
  - South Africa
    - South Africa Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - South Africa Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - South Africa Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - Saudi Arabia
    - Saudi Arabia Drug Class Outlook (Revenue, USD Million, 2014 - 2026)
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - Saudi Arabia Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - Saudi Arabia Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable
  - UAE
    - UAE Psoriatic Arthritis Treatment Market, by Drug Class
      - NSAIDs
      - DMARDs
      - 生物制剂
      - Others
    - UAE Psoriatic Arthritis Treatment Market, by Product Type
      - Prescription
      - OTC
    - UAE Psoriatic Arthritis Treatment Market, by Route of Administration
      - Topical
      - Oral
      - Injectable

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2026
Market estimates and forecast for product segments up to 2026
Regional market size and forecast for product segments up to 2026
Market estimates and forecast for application segments up to 2026
Regional market size and forecast for application segments up to 2026
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

需要一个自定义的报告吗?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.